"There is no reason anyone would want a computer in their home."
Ken Olsen, chairman and founder of Digital Equipment Corporation ; 1977
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 5354772 | Indole analogs of mevalonolactone and derivatives thereof Compounds of the formula ##STR1## wherein one of R and Ro is ##STR2## and the other is primary or secondary C1-6 alkyl not containing an asymmetric carbon atom, C3-6 cycloalkyl or phenyl-(CH2)m | 10/11/1994 |
| 5326758 | Low dose temazepam This invention relates to a hard gelatin capsule containing no more than 5 to 10 milligrams of crystalline temazepam and its use in the treatment of transient insomnia.... | 07/05/1994 |
| 5030632 | Low dose temazepam This invention relates to a hard gelatin capsule containing no more than 5 to 10 milligrams of crystalline temazepam and its use in the treatment of transient insomnia.... | 07/09/1991 |
| 5001255 | Idene analogs of mevalonolactone and derivatives thereof Compounds of the formula ##STR1## the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol level and, therefore, in the treatment of hyperlipoproteinemia and atherosclerosis, pharmaceutical compositions comprisi... | 03/19/1991 |
| 4992428 | 5-aryl-substituted-2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines The invention discloses certain 5-aryl-substituted,2,3-dihydro-imidazo[1,2-a]furo- and thieno pyridines useful as PAF receptor antagonists and for treating tumors, pharmaceutical compositions containing said compounds as an active ingredient thereof and ... | 02/12/1991 |
| 4973704 | Pyrrolyl intermediates in the synthesis of pyrrole analogs of mevalonolactone and derivatives thereof Compounds of the formula ##STR1## wherein R1 is C1-6 alkyl not containing an asymmetric carbon atom, C3-7 cycloalkyl or ##STR2## wherein R5, R6 and R7 are as defined below, R | 11/27/1990 |
| 4939159 | Azaindole derivatives useful as cholesterol biosynthesis inhibitors Compounds of the formula I: ##STR1## wherein X is the residue of an unsubstituted 6-membered aromatic ring having 3 carbon atoms and one nitrogen atom; R1 is C1-6 primary alkyl (free of asymmetric carbon atoms), or isopropyl; R | 07/03/1990 |
| 4933105 | Process for preparation of microspheres Microspheres, prepared by solvent removal from an oil-in-water emulsion using carboxylic acid salt surfactant, e.g., sodium oleate as the emulsifier.... | 06/12/1990 |
| 4927851 | Analogs of mevalonolactone and derivatives thereof Compounds of the formula ##STR1## in which Y is ##STR2## X is O or S; Z is --CHOH--CH2 --CHOH--CH2 --COOH, an ester or salt thereof or the lactone thereof; and each of R1 R2 and R3 can be al... | 05/22/1990 |
| 4892879 | 1-substituted-4-(thiazolyl-2-)-piperazines, -piperidines and tetrahydro-pyridines useful as anxioltic, psychogeriatric, antisepressant and antischiziphrenic agents Thiazoles or pharmaceutically acceptable acid addition salts thereof are useful as anxiolytic, psychogeriatric, antidepressant and antischizophrenic agents.... | 01/09/1990 |
| 4876280 | Arylcyclohexane and arylcyclohexene analogs of mevalonolactone derivatives and their use Compounds of the formula ##STR1## wherein R1 is hydrogen, C1-3 alkyl, n-butyl, i-butyl or t-butyl, R2 is hydrogen or C1-3 alkyl, R3 is hydrogen or C1-3 alkyl, R4 is hydrogen, C | 10/24/1989 |
| 4871546 | Gastrointestinal protective coating formulations Tablet formulations for the diffusable release of drugs in the gastrointestinal tract, which formulations protect the gastric mucosa from the effects of solid, gastric irritating drugs. The formulation comprises a drug tablet core, coated with a water per... | 10/03/1989 |
| 4870199 | Processes for the synthesis of diprotected R[R*,S*]-3,5-dihydroxy-6-oxohexanoate esters Process for the synthesis of compounds of the formula ##STR1## in R[R*,S*] enantiomeric form, wherein each P1 is independently an hydroxy group-protecting group, and R2z is C1-4 alkyl, benzyl or allyl, comprising, as a key... | 09/26/1989 |
| 4868319 | Process for the preparation of monoalkylcarbamate group-containing compounds An improved process for preparing monoalkylcarbamate group-containing compounds comprising reacting a hydroxy group-containing compound with an organic halide and an alkali metal cyanate in the conjoint presence of a phase transfer catalyst and a solvent.... | 09/19/1989 |
| 4851427 | Pyrrole analogs of mevalonolactone, derivatives thereof and pharmaceutical use Compounds of the formula ##STR1## wherein R1 is C1-6 alkyl not containing an asymmetric carbon atom, C3-7 cycloalkyl or ##STR2## wherein R5, R6 and R7 are as defined below, R... | 07/25/1989 |
| 4847384 | Process for the preparation of certain nitrogen-containing mono- and bicyclic ace inhibitors, and novel intermediates useful therefor An improved process for preparing certain nitrogen-containing mono- and bicyclic ACE inhibitors comprising reacting an -alkyl amino acid with a disulfide compound to form a thioester intermediate, which intermediate is then amidated with a mono- or... | 07/11/1989 |
| 4845129 | Diaryl substituted cyclopentane and cyclopentene derivatives The invention discloses certain diaryl substituted cyclopentane and cyclopentene derivatives useful as PAF inhibitors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method of using such compositions for inhibi... | 07/04/1989 |
| 4841071 | 6-substituted-4-hydroxy-tetrahydropyran-2-ones 6-Substituted-4-hydroxy-tetrahydropyran-2-ones, useful as anti-atherosclerotic agents, are obtainable by the process of the invention. The 6-substituents have a phenyl, naphthyl, tetrahydronaphthyl or indolyl nucleus bound through an ethenyl unit. The inv... | 06/20/1989 |
| 4829081 | Analogs of mevalonolactone and derivatives thereof Compounds of the formula ##STR1## in which Y is ##STR2## X is O or S; Z is --CHOH--CH2 --CHOH--CH2 --COOH, an ester or salt thereof or the lactone thereof; and each of R1, R2 and R3 can be a... | 05/09/1989 |
| 4824950 | Chiral stationary phases and columns for chromatographic resolution This invention relates to chiral compositions.... | 04/25/1989 |
| 4822799 | Pyrazolopyridine analogs of mevalonolactone and derivatives thereof useful for inhibiting cholesterol biosynthesis in mammals Compounds of the formula ##STR1## and processes for and intermediates in the synthesis thereof, pharmaceutical compositions comprising such a compound and the use of such compounds for inhibiting cholesterol biosynthesis and lowering the blood c... | 04/18/1989 |
| 4820718 | N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts and use thereof in PAF inhibition The invention discloses certain N-alkyl-(2- or 5-substituted-2-methoxycarbonyl aminoalkyl furanyl)-substituted cyclimmonium salts useful as PAF inhibitors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method ... | 04/11/1989 |
| 4808607 | Imidazole analogs of mevalonolactone and derivatives thereof for use in inhibiting cholesterol biosynthesis and lowering blood cholesterol level Compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein the various substituents are defined hereinbelow and the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol... | 02/28/1989 |
| 4804679 | Erythro-(E)-7-(3'-C1-3alkyl-1'-(3",5"-dimethylphenyl)naphth-2'-yl )-3,5-dihydroxyhept-6-enoic acids and derivatives thereof Compounds of the formula ##STR1## wherein R1 is C1-3 alkyl, and Z is ##STR2## wherein R7 is hydrogen, R8 or M, wherein R8 is a physiologically acceptable and hydrolyzable ester group, and M is a ... | 02/14/1989 |
| 4801457 | Polyacetal hydrogels formed from divinyl ethers and polyols A therapeutic composition comprising a therapeutic macromolecular agent incorporated in cross-linked polyacetal.... | 01/31/1989 |
| 4755606 | Imidazolyl-3,5-di-(diphenyl-butylsilyloxy) carboxylic acid ester intermediates Compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein the various substituents are defined herein below, the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol l... | 07/05/1988 |
| 4751235 | Anti-atherosclerotic indolizine derivatives 7-(indolizin-2-yl)hept-6-enoic acids of the formula I: ##STR1## wherein each of R1 and R2 is, independently, H, alkyl, cycloalkyl, aralkyl or aryl, ##STR2## in which R8 is H, an ester residue or cation; or the la... | 06/14/1988 |
| 4749696 | Hydroxy-[1-substituted carbonyl-2-(or 3-) piperidinyl methoxy]phosphinyloxy]-N,N,N-trialkylalkaneaminium hydroxide inner salt oxides having antitumor activity The invention discloses hydroxy-[1-substituted carbonyl-2-(or 3-) piperidinyl methoxy]phosphinyloxy]-N,N,N-trilkylalkaneaminium hydroxide inner salt oxides useful as antitumor agents, pharmaceutical compositions containing said compounds as an active ingr... | 06/07/1988 |
| 4737500 | 1-substituted-4-(thiazolyl-2-)-piperazines, -piperidines and -tetrahydropyridines useful as anxiolytic, psychogeriatric, antidepressant and antischizophrenic agents Thiazoles or pharmaceutically acceptable acid addition salts thereof are useful as anxiolytic, psychogeriatric, antidepressant and antischizophrenic agents.... | 04/12/1988 |
| 4716039 | Virus insecticide compositions Virus insecticide compositions having good stability and wettability are free-flowing particles prepared by spray-drying techniques and having the virus insecticide encapsulated in a matrix comprising an intimate mixture of a protein and clay.... | 12/29/1987 |
| 4670600 | Preparation of substituted amines Amines are substituted, e.g. alkylated, by reacting the unsubstituted amine with a ketone or aldehyde, a borohydride and a rigid acid.... | 06/02/1987 |
| 4668794 | Intermediate imidazole acrolein analogs Compounds of the formula ##STR1## and the pharmaceutically acceptable acid addition salts thereof, wherein the various substituents are defined hereinbelow, the use thereof for inhibiting cholesterol biosynthesis and lowering the blood cholesterol ... | 05/26/1987 |
| 4625039 | 4-trisubstituted silyl protected hydroxy-6-oxo-tetrahydropyran-2-yl-aldehyde intermediates 6-trans-indol-2-yl-ethenyl)-4-hydroxy-tetrahydro-2H-pyran-2-ones of formula I are obtained by a multi-step reaction involving the procedure: ##STR1## wherein p1 is trisubstituted silyl protective group, and Z is a 2-indolyl radical which m... | 11/25/1986 |
| 4619917 | Substituted 2-furanyl- or 5-oxo-2-furanyl methoxy phosphoryl alkyl cyclimmonium salts The invention discloses certain substituted 2-furanyl- or 5-oxo-2-furanyl methoxy phosphoryl alkyl cyclimmonium salts useful as PAF inhibitors, pharmaceutical compositions containing said compounds as an active ingredient thereof and a method of using suc... | 10/28/1986 |